BIOLASE (NASDAQ:BIOL) Now Covered by StockNews.com

Stock analysts at StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note issued to investors on Saturday. The brokerage set a “sell” rating on the medical technology company’s stock.

A number of other brokerages have also recently issued reports on BIOL. Ascendiant Capital Markets dropped their price target on shares of BIOLASE from $3.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. Benchmark reaffirmed a “speculative buy” rating and issued a $0.40 target price on shares of BIOLASE in a report on Wednesday, October 2nd.

BIOLASE Stock Performance

Shares of BIOL opened at $0.02 on Friday. BIOLASE has a fifty-two week low of $0.02 and a fifty-two week high of $1.94. The firm’s 50-day simple moving average is $0.05 and its two-hundred day simple moving average is $0.10. The stock has a market cap of $581,281.80, a PE ratio of 0.00 and a beta of 0.67.

BIOLASE (NASDAQ:BIOL) last posted its quarterly earnings results on Thursday, August 8th. The medical technology company reported ($0.08) earnings per share for the quarter. The company had revenue of $11.56 million during the quarter. BIOLASE had a negative return on equity of 1,782.73% and a negative net margin of 41.65%.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC grew its position in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 143,537 shares of the medical technology company’s stock after buying an additional 131,248 shares during the quarter. Virtu Financial LLC owned 0.43% of BIOLASE worth $27,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 8.79% of the company’s stock.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.